Emergence of multi-drug resistant organisms (MDROs) causing Fournier's gangrene

Journal of Infection

Volumn 76, Issue 1, 2018, Pages 38-43

  Chia, Laura ^a   Crum Cianflone, Nancy F ^a  

^a SCRIPPS MERCY HOSPITAL   (United States)

Author keywords

Epidemiology; Fournier's gangrene; MDRO; MRSA; Multi drug resistant organisms; Necrotizing fasciitis; Outcome; Risk factors; Treatment

Indexed keywords

CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; HEMOGLOBIN A1C; ILLICIT DRUG; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ADULT; ADVERSE OUTCOME; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL OUTCOME; DIABETES MELLITUS; DRUG USE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; FOURNIER GANGRENE; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OBESITY; ORCHIECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS; ADOLESCENT; BACTERIUM; DRUG EFFECT; FUNGUS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, FUNGAL; FEMALE; FOURNIER GANGRENE; FUNGI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85030863218     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2017.09.015     Document Type: Article

References (19)

1. Shyam, D.C., Rapsang, A.G., Fournier's gangrene. Surgeon 11 (2013), 222–232.
2. Eke, N., Fournier's gangrene: a review of 1726 cases. Br J Surg 87 (2000), 718–728.
3. Kincius, M., Telksnys, T., Trumbeckas, D., Jievaltas, M., Milonas, D., Evaluation of LRINEC scale feasibility for predicting outcomes of Fournier gangrene. Surg Infect (Larchmt) 17 (2016), 448–453.
4. Smith, G.L., Bunker, C.B., Dinneen, M.D., Fournier's gangrene. Br J Urol 81 (1998), 347–355.
5. Laor, E., Palmer, L.S., Tolia, B.M., Reid, R.E., Winter, H.I., Outcome prediction in patients with Fournier's gangrene. J Urol 154 (1995), 89–92.
6. Centers for Disease Control and Prevention, Management of multidrug-resistant organisms in healthcare settings. Available from: https://www.cdc.gov/mrsa/pdf/mdroguideline2006.pdf, 2006. (Accessed 1 March 2017)
7. Paterson, D.L., Bonomo, R.A., Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18 (2005), 657–686.
8. Bjurlin, M.A., O'Grady, T., Kim, D.Y., Divakaruni, N., Drago, A., Blumetti, J., et al. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology 81:4 (2013), 752–758.
9. Sorensen, M.D., Krieger, J.N., Fournier's Gangrene: epidemiology and outcomes in the general US population. Urol Int 97 (2016), 249–259.
10. Miller, L.G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A.S., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 (2005), 1445–1453.
11. Fajdic, J., Gotovac, N., Hrgovic, Z., Fournier gangrene: our approach and patients. Urol Int 87 (2011), 186–191.
12. Burton, M.J., Shah, P., Swiatlo, E., Community-acquired methicillin-resistant Staphylococcus aureus as a cause of Fournier's gangrene. Am J Med Sci 335 (2008), 327–328.
13. Vaidyanathan, S., Soni, B.M., Hughes, P.L., Mansour, P., Singh, G., Darroch, J., et al. Localised necrosis of scrotum (Fournier's gangrene) in a spinal cord injury patient – a case report. BMC Fam Pract, 3, 2002, 20.
14. Kalorin, C.M., Tobin, E.H., Community associated methicillin resistant Staphylococcus aureus causing Fournier's gangrene and genital infections. J Urol 177 (2007), 967–971.
15. Tahmaz, L., Erdemir, F., Kibar, Y., Cosar, A., Yalcyn, O., Fournier's gangrene: report of thirty-three cases and a review of the literature. Int J Urol 13 (2006), 960–967.
16. Unalp, H., Kamer, E., Derici, H., Atahan, K., Balci, U., Demirdoven, C., et al. Fournier's gangrene: evaluation of 68 patients and analysis of prognostic variables. J Postgrad Med 54 (2008), 102–105.
17. Lin, W.T., Chao, C.M., Lin, H.L., Hung, M.C., Lai, C.C., Emergence of antibiotic-resistant bacteria in patients with Fournier gangrene. Surg Infect (Larchmt) 16 (2015), 165–168.
18. Smaldone, M.C., Corcoran, A.T., Davies, B.J., Fournier gangrene: advances in clinical management. AUA Update Ser 29 (2010), 170–179.
19. Carapetis, J.R., Jacoby, P., Carville, K., Ang, S.J., Curtis, N., Andrews, R., Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections. Clin Infect Dis 59 (2014), 358–365.